Bowel (colorectal) cancer
to check the Effect and Safety of Nuvastatic in Reducing Cancer Related Fatigue in Colon Cancer Patients
Who can joinWomen
AgeAsk the trial team
Kind of studyPhase 3: compared with usual treatment
What it testsSee the registry
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Ardent Clinical Research ServicesIndiaDirections ↗
Registry summary (technical)
Phase III Randomized Double Blind Placebo Controlled Study to Evaluate the Efficacy and Safety of Nuvastatic in Reducing Cancer Related Fatigue in Colon Cancer Patients Undergoing First Line Chemotherapy - NIL
Sponsor: Natureceuticals Sdn Bhd
CTRI/2025/05/087937 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 30 Mar 2026 · read by us 5 Nov 2026